(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

LN

ST13

US500000090831436

Class

1

Filing

90831436

Registration

7009081

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

24

Latest update

03/28/2023

Trademark type

Combined

Nice classes

1

Filing date

07/15/2021

Registration date

03/28/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/28/2023

Last transaction

03/28/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

SHANDONG PROVINCE, CN

Examiner

GALBO, AMANDA

Law office

N70

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized design of a globe with Chinese lettering inside the parallels and flanked by the letter "L" with an extended underline and the letter "N" on the right.

Holders and representatives

Holders

Lunan Pharmaceutical Group Co., Ltd.

Representatives

Paulo A. de Almeida PATEL & ALMEIDA, P. C.

Technical classification

Nice Classes

Class 1

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Active chemical ingredients for use in the manufacture of pharmaceuticals and pharmaceutical substances for the treatment of anaphylactic reactionspaininflammationcanceroncological diseasesdiabetesobesitycancercardiovascular and cerebrovascular diseasescoldscoughinfluenzarespiratory diseases and asthmagastrointestinal diseasesgenitourinary diseasesneurological diseasesallergiesheadachesinsomniabacteria-based diseasesocular disorders or diseases; active chemical ingredients for use in the manufacture of anti-inflammatory pharmaceutical preparations

Publications

History of USPTO decisions and trademark events.

24 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

03/28/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

03/28/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/10/2023

PUBO

PUBLISHED FOR OPPOSITION

01/10/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/21/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/07/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

12/07/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

12/07/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

12/07/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

12/07/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/02/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/02/2022

ALIE

ASSIGNED TO LIE

12/02/2022

NREV

NOTICE OF REVIVAL - E-MAILED

10/14/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/13/2022

PETG

PETITION TO REVIVE-GRANTED

10/13/2022

PROA

TEAS PETITION TO REVIVE RECEIVED

10/13/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/11/2022

GNRT

NON-FINAL ACTION E-MAILED

04/11/2022

CNRT

NON-FINAL ACTION WRITTEN

04/11/2022

DOCK

ASSIGNED TO EXAMINER

04/05/2022

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

09/22/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/21/2021

NWAP

NEW APPLICATION ENTERED

07/19/2021

Continuous trademark protection

Get notified about every new filing that threatens LN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.